01
Apr

AstraZeneca’s AZD0530 proved a disappointment as a new drug for solid tumors, but a Yale team says it may prove more effective in a new program for Alzheimer’s.

…read more

Source: Yale team says failed AstraZeneca drug shows promise in Alzheimer’s

    

0 No comments